Philip McCarthy, MD, Director of the Blood and Marrow Transplant Center at Roswell Park Cancer Institute in Buffalo, NY, shares benefits of lenalidomide maintenance therapy for multiple myeloma patients.
REVLIMID (Lenalidomide) Maintenance Therapy Approved for Multiple Myeloma Patients
